03:15 AM EST, 11/05/2026 (MT Newswires) -- Siemens Healthineers (SHL.F) intends to spin off its in vitro diagnostics business as it plans to rebrand itself as Healthineers. The medical technology company launched the carve-out process for the unit, which will operate as a standalone entity under the name Olyrian Diagnostics, according to a Thursday release. The transition, to be rolled out in phases, is expected to be completed by mid-2028. The unit will remain part of Siemens Healthineers during the transition.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.